Non Melanoma Malignant Neoplasm of the Skin B046

Current RMA Instruments:
 
Reasonable Hypothesis SOP
78 of 2024
Balance of Probabilities SOP
79 of 2024
Changes from previous Instruments:

 

ICD Coding:
  • ICD-10-AM Codes: C00.0, C00.1, C00.2, C00.6, C00.8, C00.9, C44, C51.0, C51.1, C51.2, C51.8, C51.9, C60.0, C60.1, C60.2, C60.8, C60.9, C63.2, D04, D07.1, D07.4
Brief description:

Non melanoma malignant neoplasms are cancers that arise from skin cells other than melanocytes. The two main types are basal and squamous cell carcinoma of the skin. Basal cell carcinomas are the most common and make up approximately 70% of non-melanoma skin cancers. 

 

Confirming the diagnosis:

To confirm the diagnosis, there needs to be a histopathology report confirming a non-melanoma malignant neoplasm (with the specific diagnosis). 

To establish this diagnosis, the assessment and/or management may involve consultation with the following medical specialists: a dermatologist, a plastic surgeon and/or an oncologist. 

Diagnoses covered by SOP
  • Basal cell carcinoma (BCC) of the skin 
  • Bowen’s disease
  • Carcinoma-in-situ of the skin
  • Squamous cell carcinoma (SCC) of the skin
  • BCC or SCC of anogenital skin (including skin of penis)
  • Non-melanoma malignant neoplasm of the external aspect of the lip (lipstick area), subungual skin (area beneath the nail plate of a finger or toe), external auditory canal skin (in the ear), and anogenital skin 
Conditions not covered by SOP
  • Carcinoid tumour #
  • Hodgkin lymphoma *
  • Kaposi’s sarcoma of the skin *
  • Keratoacanthoma #
  • Lymphoma of the skin* - Hodgkin's lymphoma or non-Hodgkin's lymphoma
  • Malignant melanoma of the skin*
  • Mammary and extramammary Paget disease * Malignant neoplasm of the breast or non-SoP
  • Merkel cell carcinoma *
  • Non-melanoma malignant neoplasm mucosa lining the oral (inner aspects of the lips, conjunctiva and anogenital mucosa) #
  • Non-Hodgkin lymphoma *
  • Soft tissue sarcoma* of the skin
  • Solar keratosis*

* another SOP applies  - the SOP has the same name unless otherwise specified

# non-SOP condition

Clinical onset

The clinical onset is defined as the first appearance of clinical signs consistent with a non-melanoma malignant neoplasm, as documented by the treating doctor, and subsequently confirmed by histopathology examination. 

Clinical worsening

For clinical worsening, the SOP only has an 'inability to obtain appropriate clinical management factor.'  Failure to undergo timely treatment could result in permanent worsening in the form or local invasion/destruction of normal tissue, metastasis or death from the disease.

 

Source URL: https://clik.dva.gov.au/ccps-medical-research-library/sops-grouped-icd-body-system/n-p/non-melanotic-malignant-neoplasm-skin-b046-c000c001c002c00

Last amended

Factors in CCPS as at 26 September 2007 (B046)

Current RMA Instruments:
 
Reasonable Hypothesis SOP
78 of 2024
Balance of Probabilities SOP
79 of 2024
Changes from previous Instruments:

 

ICD Coding:
  • ICD-10-AM Codes: C00.0, C00.1, C00.2, C00.6, C00.8, C00.9, C44, C51.0, C51.1, C51.2, C51.8, C51.9, C60.0, C60.1, C60.2, C60.8, C60.9, C63.2, D04, D07.1, D07.4
Brief description:

Non melanoma malignant neoplasms are cancers that arise from skin cells other than melanocytes. The two main types are basal and squamous cell carcinoma of the skin. Basal cell carcinomas are the most common and make up approximately 70% of non-melanoma skin cancers. 

 

Confirming the diagnosis:

To confirm the diagnosis, there needs to be a histopathology report confirming a non-melanoma malignant neoplasm (with the specific diagnosis). 

To establish this diagnosis, the assessment and/or management may involve consultation with the following medical specialists: a dermatologist, a plastic surgeon and/or an oncologist. 

Diagnoses covered by SOP
  • Basal cell carcinoma (BCC) of the skin 
  • Bowen’s disease
  • Carcinoma-in-situ of the skin
  • Squamous cell carcinoma (SCC) of the skin
  • BCC or SCC of anogenital skin (including skin of penis)
  • Non-melanoma malignant neoplasm of the external aspect of the lip (lipstick area), subungual skin (area beneath the nail plate of a finger or toe), external auditory canal skin (in the ear), and anogenital skin 
Conditions not covered by SOP
  • Carcinoid tumour #
  • Hodgkin lymphoma *
  • Kaposi’s sarcoma of the skin *
  • Keratoacanthoma #
  • Lymphoma of the skin* - Hodgkin's lymphoma or non-Hodgkin's lymphoma
  • Malignant melanoma of the skin*
  • Mammary and extramammary Paget disease * Malignant neoplasm of the breast or non-SoP
  • Merkel cell carcinoma *
  • Non-melanoma malignant neoplasm mucosa lining the oral (inner aspects of the lips, conjunctiva and anogenital mucosa) #
  • Non-Hodgkin lymphoma *
  • Soft tissue sarcoma* of the skin
  • Solar keratosis*

* another SOP applies  - the SOP has the same name unless otherwise specified

# non-SOP condition

Clinical onset

The clinical onset is defined as the first appearance of clinical signs consistent with a non-melanoma malignant neoplasm, as documented by the treating doctor, and subsequently confirmed by histopathology examination. 

Clinical worsening

For clinical worsening, the SOP only has an 'inability to obtain appropriate clinical management factor.'  Failure to undergo timely treatment could result in permanent worsening in the form or local invasion/destruction of normal tissue, metastasis or death from the disease.

 

Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/n-p/rulebase-non-melanotic-malignant-neoplasm-skin

Last amended

A course of therapeutic radiation

Current RMA Instruments:
 
Reasonable Hypothesis SOP
78 of 2024
Balance of Probabilities SOP
79 of 2024
Changes from previous Instruments:

 

ICD Coding:
  • ICD-10-AM Codes: C00.0, C00.1, C00.2, C00.6, C00.8, C00.9, C44, C51.0, C51.1, C51.2, C51.8, C51.9, C60.0, C60.1, C60.2, C60.8, C60.9, C63.2, D04, D07.1, D07.4
Brief description:

Non melanoma malignant neoplasms are cancers that arise from skin cells other than melanocytes. The two main types are basal and squamous cell carcinoma of the skin. Basal cell carcinomas are the most common and make up approximately 70% of non-melanoma skin cancers. 

 

Confirming the diagnosis:

To confirm the diagnosis, there needs to be a histopathology report confirming a non-melanoma malignant neoplasm (with the specific diagnosis). 

To establish this diagnosis, the assessment and/or management may involve consultation with the following medical specialists: a dermatologist, a plastic surgeon and/or an oncologist. 

Diagnoses covered by SOP
  • Basal cell carcinoma (BCC) of the skin 
  • Bowen’s disease
  • Carcinoma-in-situ of the skin
  • Squamous cell carcinoma (SCC) of the skin
  • BCC or SCC of anogenital skin (including skin of penis)
  • Non-melanoma malignant neoplasm of the external aspect of the lip (lipstick area), subungual skin (area beneath the nail plate of a finger or toe), external auditory canal skin (in the ear), and anogenital skin 
Conditions not covered by SOP
  • Carcinoid tumour #
  • Hodgkin lymphoma *
  • Kaposi’s sarcoma of the skin *
  • Keratoacanthoma #
  • Lymphoma of the skin* - Hodgkin's lymphoma or non-Hodgkin's lymphoma
  • Malignant melanoma of the skin*
  • Mammary and extramammary Paget disease * Malignant neoplasm of the breast or non-SoP
  • Merkel cell carcinoma *
  • Non-melanoma malignant neoplasm mucosa lining the oral (inner aspects of the lips, conjunctiva and anogenital mucosa) #
  • Non-Hodgkin lymphoma *
  • Soft tissue sarcoma* of the skin
  • Solar keratosis*

* another SOP applies  - the SOP has the same name unless otherwise specified

# non-SOP condition

Clinical onset

The clinical onset is defined as the first appearance of clinical signs consistent with a non-melanoma malignant neoplasm, as documented by the treating doctor, and subsequently confirmed by histopathology examination. 

Clinical worsening

For clinical worsening, the SOP only has an 'inability to obtain appropriate clinical management factor.'  Failure to undergo timely treatment could result in permanent worsening in the form or local invasion/destruction of normal tissue, metastasis or death from the disease.

 

Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/n-p/non-melanotic-malignant-neoplasm-skin-b046-c000c001c002c00/rulebase-non-melanotic-malignant-neoplasm-skin/course-therapeutic-radiation

Last amended

Atomic radiation

Current RMA Instruments:
 
Reasonable Hypothesis SOP
78 of 2024
Balance of Probabilities SOP
79 of 2024
Changes from previous Instruments:

 

ICD Coding:
  • ICD-10-AM Codes: C00.0, C00.1, C00.2, C00.6, C00.8, C00.9, C44, C51.0, C51.1, C51.2, C51.8, C51.9, C60.0, C60.1, C60.2, C60.8, C60.9, C63.2, D04, D07.1, D07.4
Brief description:

Non melanoma malignant neoplasms are cancers that arise from skin cells other than melanocytes. The two main types are basal and squamous cell carcinoma of the skin. Basal cell carcinomas are the most common and make up approximately 70% of non-melanoma skin cancers. 

 

Confirming the diagnosis:

To confirm the diagnosis, there needs to be a histopathology report confirming a non-melanoma malignant neoplasm (with the specific diagnosis). 

To establish this diagnosis, the assessment and/or management may involve consultation with the following medical specialists: a dermatologist, a plastic surgeon and/or an oncologist. 

Diagnoses covered by SOP
  • Basal cell carcinoma (BCC) of the skin 
  • Bowen’s disease
  • Carcinoma-in-situ of the skin
  • Squamous cell carcinoma (SCC) of the skin
  • BCC or SCC of anogenital skin (including skin of penis)
  • Non-melanoma malignant neoplasm of the external aspect of the lip (lipstick area), subungual skin (area beneath the nail plate of a finger or toe), external auditory canal skin (in the ear), and anogenital skin 
Conditions not covered by SOP
  • Carcinoid tumour #
  • Hodgkin lymphoma *
  • Kaposi’s sarcoma of the skin *
  • Keratoacanthoma #
  • Lymphoma of the skin* - Hodgkin's lymphoma or non-Hodgkin's lymphoma
  • Malignant melanoma of the skin*
  • Mammary and extramammary Paget disease * Malignant neoplasm of the breast or non-SoP
  • Merkel cell carcinoma *
  • Non-melanoma malignant neoplasm mucosa lining the oral (inner aspects of the lips, conjunctiva and anogenital mucosa) #
  • Non-Hodgkin lymphoma *
  • Soft tissue sarcoma* of the skin
  • Solar keratosis*

* another SOP applies  - the SOP has the same name unless otherwise specified

# non-SOP condition

Clinical onset

The clinical onset is defined as the first appearance of clinical signs consistent with a non-melanoma malignant neoplasm, as documented by the treating doctor, and subsequently confirmed by histopathology examination. 

Clinical worsening

For clinical worsening, the SOP only has an 'inability to obtain appropriate clinical management factor.'  Failure to undergo timely treatment could result in permanent worsening in the form or local invasion/destruction of normal tissue, metastasis or death from the disease.

 

Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/n-p/non-melanotic-malignant-neoplasm-skin-b046-c000c001c002c00/rulebase-non-melanotic-malignant-neoplasm-skin/atomic-radiation

Last amended

Cigar smoking

Current RMA Instruments:
 
Reasonable Hypothesis SOP
78 of 2024
Balance of Probabilities SOP
79 of 2024
Changes from previous Instruments:

 

ICD Coding:
  • ICD-10-AM Codes: C00.0, C00.1, C00.2, C00.6, C00.8, C00.9, C44, C51.0, C51.1, C51.2, C51.8, C51.9, C60.0, C60.1, C60.2, C60.8, C60.9, C63.2, D04, D07.1, D07.4
Brief description:

Non melanoma malignant neoplasms are cancers that arise from skin cells other than melanocytes. The two main types are basal and squamous cell carcinoma of the skin. Basal cell carcinomas are the most common and make up approximately 70% of non-melanoma skin cancers. 

 

Confirming the diagnosis:

To confirm the diagnosis, there needs to be a histopathology report confirming a non-melanoma malignant neoplasm (with the specific diagnosis). 

To establish this diagnosis, the assessment and/or management may involve consultation with the following medical specialists: a dermatologist, a plastic surgeon and/or an oncologist. 

Diagnoses covered by SOP
  • Basal cell carcinoma (BCC) of the skin 
  • Bowen’s disease
  • Carcinoma-in-situ of the skin
  • Squamous cell carcinoma (SCC) of the skin
  • BCC or SCC of anogenital skin (including skin of penis)
  • Non-melanoma malignant neoplasm of the external aspect of the lip (lipstick area), subungual skin (area beneath the nail plate of a finger or toe), external auditory canal skin (in the ear), and anogenital skin 
Conditions not covered by SOP
  • Carcinoid tumour #
  • Hodgkin lymphoma *
  • Kaposi’s sarcoma of the skin *
  • Keratoacanthoma #
  • Lymphoma of the skin* - Hodgkin's lymphoma or non-Hodgkin's lymphoma
  • Malignant melanoma of the skin*
  • Mammary and extramammary Paget disease * Malignant neoplasm of the breast or non-SoP
  • Merkel cell carcinoma *
  • Non-melanoma malignant neoplasm mucosa lining the oral (inner aspects of the lips, conjunctiva and anogenital mucosa) #
  • Non-Hodgkin lymphoma *
  • Soft tissue sarcoma* of the skin
  • Solar keratosis*

* another SOP applies  - the SOP has the same name unless otherwise specified

# non-SOP condition

Clinical onset

The clinical onset is defined as the first appearance of clinical signs consistent with a non-melanoma malignant neoplasm, as documented by the treating doctor, and subsequently confirmed by histopathology examination. 

Clinical worsening

For clinical worsening, the SOP only has an 'inability to obtain appropriate clinical management factor.'  Failure to undergo timely treatment could result in permanent worsening in the form or local invasion/destruction of normal tissue, metastasis or death from the disease.

 

Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/n-p/non-melanotic-malignant-neoplasm-skin-b046-c000c001c002c00/rulebase-non-melanotic-malignant-neoplasm-skin/cigar-smoking

Last amended

Cigarette smoking

Current RMA Instruments:
 
Reasonable Hypothesis SOP
78 of 2024
Balance of Probabilities SOP
79 of 2024
Changes from previous Instruments:

 

ICD Coding:
  • ICD-10-AM Codes: C00.0, C00.1, C00.2, C00.6, C00.8, C00.9, C44, C51.0, C51.1, C51.2, C51.8, C51.9, C60.0, C60.1, C60.2, C60.8, C60.9, C63.2, D04, D07.1, D07.4
Brief description:

Non melanoma malignant neoplasms are cancers that arise from skin cells other than melanocytes. The two main types are basal and squamous cell carcinoma of the skin. Basal cell carcinomas are the most common and make up approximately 70% of non-melanoma skin cancers. 

 

Confirming the diagnosis:

To confirm the diagnosis, there needs to be a histopathology report confirming a non-melanoma malignant neoplasm (with the specific diagnosis). 

To establish this diagnosis, the assessment and/or management may involve consultation with the following medical specialists: a dermatologist, a plastic surgeon and/or an oncologist. 

Diagnoses covered by SOP
  • Basal cell carcinoma (BCC) of the skin 
  • Bowen’s disease
  • Carcinoma-in-situ of the skin
  • Squamous cell carcinoma (SCC) of the skin
  • BCC or SCC of anogenital skin (including skin of penis)
  • Non-melanoma malignant neoplasm of the external aspect of the lip (lipstick area), subungual skin (area beneath the nail plate of a finger or toe), external auditory canal skin (in the ear), and anogenital skin 
Conditions not covered by SOP
  • Carcinoid tumour #
  • Hodgkin lymphoma *
  • Kaposi’s sarcoma of the skin *
  • Keratoacanthoma #
  • Lymphoma of the skin* - Hodgkin's lymphoma or non-Hodgkin's lymphoma
  • Malignant melanoma of the skin*
  • Mammary and extramammary Paget disease * Malignant neoplasm of the breast or non-SoP
  • Merkel cell carcinoma *
  • Non-melanoma malignant neoplasm mucosa lining the oral (inner aspects of the lips, conjunctiva and anogenital mucosa) #
  • Non-Hodgkin lymphoma *
  • Soft tissue sarcoma* of the skin
  • Solar keratosis*

* another SOP applies  - the SOP has the same name unless otherwise specified

# non-SOP condition

Clinical onset

The clinical onset is defined as the first appearance of clinical signs consistent with a non-melanoma malignant neoplasm, as documented by the treating doctor, and subsequently confirmed by histopathology examination. 

Clinical worsening

For clinical worsening, the SOP only has an 'inability to obtain appropriate clinical management factor.'  Failure to undergo timely treatment could result in permanent worsening in the form or local invasion/destruction of normal tissue, metastasis or death from the disease.

 

Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/n-p/non-melanotic-malignant-neoplasm-skin-b046-c000c001c002c00/rulebase-non-melanotic-malignant-neoplasm-skin/cigarette-smoking

Last amended

Cutaneous contact with high concentrations of polycyclic aromatic hydrocarbons

Current RMA Instruments:
 
Reasonable Hypothesis SOP
78 of 2024
Balance of Probabilities SOP
79 of 2024
Changes from previous Instruments:

 

ICD Coding:
  • ICD-10-AM Codes: C00.0, C00.1, C00.2, C00.6, C00.8, C00.9, C44, C51.0, C51.1, C51.2, C51.8, C51.9, C60.0, C60.1, C60.2, C60.8, C60.9, C63.2, D04, D07.1, D07.4
Brief description:

Non melanoma malignant neoplasms are cancers that arise from skin cells other than melanocytes. The two main types are basal and squamous cell carcinoma of the skin. Basal cell carcinomas are the most common and make up approximately 70% of non-melanoma skin cancers. 

 

Confirming the diagnosis:

To confirm the diagnosis, there needs to be a histopathology report confirming a non-melanoma malignant neoplasm (with the specific diagnosis). 

To establish this diagnosis, the assessment and/or management may involve consultation with the following medical specialists: a dermatologist, a plastic surgeon and/or an oncologist. 

Diagnoses covered by SOP
  • Basal cell carcinoma (BCC) of the skin 
  • Bowen’s disease
  • Carcinoma-in-situ of the skin
  • Squamous cell carcinoma (SCC) of the skin
  • BCC or SCC of anogenital skin (including skin of penis)
  • Non-melanoma malignant neoplasm of the external aspect of the lip (lipstick area), subungual skin (area beneath the nail plate of a finger or toe), external auditory canal skin (in the ear), and anogenital skin 
Conditions not covered by SOP
  • Carcinoid tumour #
  • Hodgkin lymphoma *
  • Kaposi’s sarcoma of the skin *
  • Keratoacanthoma #
  • Lymphoma of the skin* - Hodgkin's lymphoma or non-Hodgkin's lymphoma
  • Malignant melanoma of the skin*
  • Mammary and extramammary Paget disease * Malignant neoplasm of the breast or non-SoP
  • Merkel cell carcinoma *
  • Non-melanoma malignant neoplasm mucosa lining the oral (inner aspects of the lips, conjunctiva and anogenital mucosa) #
  • Non-Hodgkin lymphoma *
  • Soft tissue sarcoma* of the skin
  • Solar keratosis*

* another SOP applies  - the SOP has the same name unless otherwise specified

# non-SOP condition

Clinical onset

The clinical onset is defined as the first appearance of clinical signs consistent with a non-melanoma malignant neoplasm, as documented by the treating doctor, and subsequently confirmed by histopathology examination. 

Clinical worsening

For clinical worsening, the SOP only has an 'inability to obtain appropriate clinical management factor.'  Failure to undergo timely treatment could result in permanent worsening in the form or local invasion/destruction of normal tissue, metastasis or death from the disease.

 

Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/n-p/non-melanotic-malignant-neoplasm-skin-b046-c000c001c002c00/rulebase-non-melanotic-malignant-neoplasm-skin/cutaneous-contact-high-concentrations-polycyclic-aromatic-hydrocarbons

Last amended

Cutaneous contact with mustard gas

Current RMA Instruments:
 
Reasonable Hypothesis SOP
78 of 2024
Balance of Probabilities SOP
79 of 2024
Changes from previous Instruments:

 

ICD Coding:
  • ICD-10-AM Codes: C00.0, C00.1, C00.2, C00.6, C00.8, C00.9, C44, C51.0, C51.1, C51.2, C51.8, C51.9, C60.0, C60.1, C60.2, C60.8, C60.9, C63.2, D04, D07.1, D07.4
Brief description:

Non melanoma malignant neoplasms are cancers that arise from skin cells other than melanocytes. The two main types are basal and squamous cell carcinoma of the skin. Basal cell carcinomas are the most common and make up approximately 70% of non-melanoma skin cancers. 

 

Confirming the diagnosis:

To confirm the diagnosis, there needs to be a histopathology report confirming a non-melanoma malignant neoplasm (with the specific diagnosis). 

To establish this diagnosis, the assessment and/or management may involve consultation with the following medical specialists: a dermatologist, a plastic surgeon and/or an oncologist. 

Diagnoses covered by SOP
  • Basal cell carcinoma (BCC) of the skin 
  • Bowen’s disease
  • Carcinoma-in-situ of the skin
  • Squamous cell carcinoma (SCC) of the skin
  • BCC or SCC of anogenital skin (including skin of penis)
  • Non-melanoma malignant neoplasm of the external aspect of the lip (lipstick area), subungual skin (area beneath the nail plate of a finger or toe), external auditory canal skin (in the ear), and anogenital skin 
Conditions not covered by SOP
  • Carcinoid tumour #
  • Hodgkin lymphoma *
  • Kaposi’s sarcoma of the skin *
  • Keratoacanthoma #
  • Lymphoma of the skin* - Hodgkin's lymphoma or non-Hodgkin's lymphoma
  • Malignant melanoma of the skin*
  • Mammary and extramammary Paget disease * Malignant neoplasm of the breast or non-SoP
  • Merkel cell carcinoma *
  • Non-melanoma malignant neoplasm mucosa lining the oral (inner aspects of the lips, conjunctiva and anogenital mucosa) #
  • Non-Hodgkin lymphoma *
  • Soft tissue sarcoma* of the skin
  • Solar keratosis*

* another SOP applies  - the SOP has the same name unless otherwise specified

# non-SOP condition

Clinical onset

The clinical onset is defined as the first appearance of clinical signs consistent with a non-melanoma malignant neoplasm, as documented by the treating doctor, and subsequently confirmed by histopathology examination. 

Clinical worsening

For clinical worsening, the SOP only has an 'inability to obtain appropriate clinical management factor.'  Failure to undergo timely treatment could result in permanent worsening in the form or local invasion/destruction of normal tissue, metastasis or death from the disease.

 

Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/n-p/non-melanotic-malignant-neoplasm-skin-b046-c000c001c002c00/rulebase-non-melanotic-malignant-neoplasm-skin/cutaneous-contact-mustard-gas

Last amended

Cutaneous contact with paraquat or bipyridine

Current RMA Instruments:
 
Reasonable Hypothesis SOP
78 of 2024
Balance of Probabilities SOP
79 of 2024
Changes from previous Instruments:

 

ICD Coding:
  • ICD-10-AM Codes: C00.0, C00.1, C00.2, C00.6, C00.8, C00.9, C44, C51.0, C51.1, C51.2, C51.8, C51.9, C60.0, C60.1, C60.2, C60.8, C60.9, C63.2, D04, D07.1, D07.4
Brief description:

Non melanoma malignant neoplasms are cancers that arise from skin cells other than melanocytes. The two main types are basal and squamous cell carcinoma of the skin. Basal cell carcinomas are the most common and make up approximately 70% of non-melanoma skin cancers. 

 

Confirming the diagnosis:

To confirm the diagnosis, there needs to be a histopathology report confirming a non-melanoma malignant neoplasm (with the specific diagnosis). 

To establish this diagnosis, the assessment and/or management may involve consultation with the following medical specialists: a dermatologist, a plastic surgeon and/or an oncologist. 

Diagnoses covered by SOP
  • Basal cell carcinoma (BCC) of the skin 
  • Bowen’s disease
  • Carcinoma-in-situ of the skin
  • Squamous cell carcinoma (SCC) of the skin
  • BCC or SCC of anogenital skin (including skin of penis)
  • Non-melanoma malignant neoplasm of the external aspect of the lip (lipstick area), subungual skin (area beneath the nail plate of a finger or toe), external auditory canal skin (in the ear), and anogenital skin 
Conditions not covered by SOP
  • Carcinoid tumour #
  • Hodgkin lymphoma *
  • Kaposi’s sarcoma of the skin *
  • Keratoacanthoma #
  • Lymphoma of the skin* - Hodgkin's lymphoma or non-Hodgkin's lymphoma
  • Malignant melanoma of the skin*
  • Mammary and extramammary Paget disease * Malignant neoplasm of the breast or non-SoP
  • Merkel cell carcinoma *
  • Non-melanoma malignant neoplasm mucosa lining the oral (inner aspects of the lips, conjunctiva and anogenital mucosa) #
  • Non-Hodgkin lymphoma *
  • Soft tissue sarcoma* of the skin
  • Solar keratosis*

* another SOP applies  - the SOP has the same name unless otherwise specified

# non-SOP condition

Clinical onset

The clinical onset is defined as the first appearance of clinical signs consistent with a non-melanoma malignant neoplasm, as documented by the treating doctor, and subsequently confirmed by histopathology examination. 

Clinical worsening

For clinical worsening, the SOP only has an 'inability to obtain appropriate clinical management factor.'  Failure to undergo timely treatment could result in permanent worsening in the form or local invasion/destruction of normal tissue, metastasis or death from the disease.

 

Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/n-p/non-melanotic-malignant-neoplasm-skin-b046-c000c001c002c00/rulebase-non-melanotic-malignant-neoplasm-skin/cutaneous-contact-paraquat-or-bipyridine

Last amended

Cutaneous scarring

Current RMA Instruments:
 
Reasonable Hypothesis SOP
78 of 2024
Balance of Probabilities SOP
79 of 2024
Changes from previous Instruments:

 

ICD Coding:
  • ICD-10-AM Codes: C00.0, C00.1, C00.2, C00.6, C00.8, C00.9, C44, C51.0, C51.1, C51.2, C51.8, C51.9, C60.0, C60.1, C60.2, C60.8, C60.9, C63.2, D04, D07.1, D07.4
Brief description:

Non melanoma malignant neoplasms are cancers that arise from skin cells other than melanocytes. The two main types are basal and squamous cell carcinoma of the skin. Basal cell carcinomas are the most common and make up approximately 70% of non-melanoma skin cancers. 

 

Confirming the diagnosis:

To confirm the diagnosis, there needs to be a histopathology report confirming a non-melanoma malignant neoplasm (with the specific diagnosis). 

To establish this diagnosis, the assessment and/or management may involve consultation with the following medical specialists: a dermatologist, a plastic surgeon and/or an oncologist. 

Diagnoses covered by SOP
  • Basal cell carcinoma (BCC) of the skin 
  • Bowen’s disease
  • Carcinoma-in-situ of the skin
  • Squamous cell carcinoma (SCC) of the skin
  • BCC or SCC of anogenital skin (including skin of penis)
  • Non-melanoma malignant neoplasm of the external aspect of the lip (lipstick area), subungual skin (area beneath the nail plate of a finger or toe), external auditory canal skin (in the ear), and anogenital skin 
Conditions not covered by SOP
  • Carcinoid tumour #
  • Hodgkin lymphoma *
  • Kaposi’s sarcoma of the skin *
  • Keratoacanthoma #
  • Lymphoma of the skin* - Hodgkin's lymphoma or non-Hodgkin's lymphoma
  • Malignant melanoma of the skin*
  • Mammary and extramammary Paget disease * Malignant neoplasm of the breast or non-SoP
  • Merkel cell carcinoma *
  • Non-melanoma malignant neoplasm mucosa lining the oral (inner aspects of the lips, conjunctiva and anogenital mucosa) #
  • Non-Hodgkin lymphoma *
  • Soft tissue sarcoma* of the skin
  • Solar keratosis*

* another SOP applies  - the SOP has the same name unless otherwise specified

# non-SOP condition

Clinical onset

The clinical onset is defined as the first appearance of clinical signs consistent with a non-melanoma malignant neoplasm, as documented by the treating doctor, and subsequently confirmed by histopathology examination. 

Clinical worsening

For clinical worsening, the SOP only has an 'inability to obtain appropriate clinical management factor.'  Failure to undergo timely treatment could result in permanent worsening in the form or local invasion/destruction of normal tissue, metastasis or death from the disease.

 

Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/n-p/non-melanotic-malignant-neoplasm-skin-b046-c000c001c002c00/rulebase-non-melanotic-malignant-neoplasm-skin/cutaneous-scarring

Last amended

Cutaneous ulceration

Current RMA Instruments:
 
Reasonable Hypothesis SOP
78 of 2024
Balance of Probabilities SOP
79 of 2024
Changes from previous Instruments:

 

ICD Coding:
  • ICD-10-AM Codes: C00.0, C00.1, C00.2, C00.6, C00.8, C00.9, C44, C51.0, C51.1, C51.2, C51.8, C51.9, C60.0, C60.1, C60.2, C60.8, C60.9, C63.2, D04, D07.1, D07.4
Brief description:

Non melanoma malignant neoplasms are cancers that arise from skin cells other than melanocytes. The two main types are basal and squamous cell carcinoma of the skin. Basal cell carcinomas are the most common and make up approximately 70% of non-melanoma skin cancers. 

 

Confirming the diagnosis:

To confirm the diagnosis, there needs to be a histopathology report confirming a non-melanoma malignant neoplasm (with the specific diagnosis). 

To establish this diagnosis, the assessment and/or management may involve consultation with the following medical specialists: a dermatologist, a plastic surgeon and/or an oncologist. 

Diagnoses covered by SOP
  • Basal cell carcinoma (BCC) of the skin 
  • Bowen’s disease
  • Carcinoma-in-situ of the skin
  • Squamous cell carcinoma (SCC) of the skin
  • BCC or SCC of anogenital skin (including skin of penis)
  • Non-melanoma malignant neoplasm of the external aspect of the lip (lipstick area), subungual skin (area beneath the nail plate of a finger or toe), external auditory canal skin (in the ear), and anogenital skin 
Conditions not covered by SOP
  • Carcinoid tumour #
  • Hodgkin lymphoma *
  • Kaposi’s sarcoma of the skin *
  • Keratoacanthoma #
  • Lymphoma of the skin* - Hodgkin's lymphoma or non-Hodgkin's lymphoma
  • Malignant melanoma of the skin*
  • Mammary and extramammary Paget disease * Malignant neoplasm of the breast or non-SoP
  • Merkel cell carcinoma *
  • Non-melanoma malignant neoplasm mucosa lining the oral (inner aspects of the lips, conjunctiva and anogenital mucosa) #
  • Non-Hodgkin lymphoma *
  • Soft tissue sarcoma* of the skin
  • Solar keratosis*

* another SOP applies  - the SOP has the same name unless otherwise specified

# non-SOP condition

Clinical onset

The clinical onset is defined as the first appearance of clinical signs consistent with a non-melanoma malignant neoplasm, as documented by the treating doctor, and subsequently confirmed by histopathology examination. 

Clinical worsening

For clinical worsening, the SOP only has an 'inability to obtain appropriate clinical management factor.'  Failure to undergo timely treatment could result in permanent worsening in the form or local invasion/destruction of normal tissue, metastasis or death from the disease.

 

Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/n-p/non-melanotic-malignant-neoplasm-skin-b046-c000c001c002c00/rulebase-non-melanotic-malignant-neoplasm-skin/cutaneous-ulceration

Last amended

Exposure to arsenic

Current RMA Instruments:
 
Reasonable Hypothesis SOP
78 of 2024
Balance of Probabilities SOP
79 of 2024
Changes from previous Instruments:

 

ICD Coding:
  • ICD-10-AM Codes: C00.0, C00.1, C00.2, C00.6, C00.8, C00.9, C44, C51.0, C51.1, C51.2, C51.8, C51.9, C60.0, C60.1, C60.2, C60.8, C60.9, C63.2, D04, D07.1, D07.4
Brief description:

Non melanoma malignant neoplasms are cancers that arise from skin cells other than melanocytes. The two main types are basal and squamous cell carcinoma of the skin. Basal cell carcinomas are the most common and make up approximately 70% of non-melanoma skin cancers. 

 

Confirming the diagnosis:

To confirm the diagnosis, there needs to be a histopathology report confirming a non-melanoma malignant neoplasm (with the specific diagnosis). 

To establish this diagnosis, the assessment and/or management may involve consultation with the following medical specialists: a dermatologist, a plastic surgeon and/or an oncologist. 

Diagnoses covered by SOP
  • Basal cell carcinoma (BCC) of the skin 
  • Bowen’s disease
  • Carcinoma-in-situ of the skin
  • Squamous cell carcinoma (SCC) of the skin
  • BCC or SCC of anogenital skin (including skin of penis)
  • Non-melanoma malignant neoplasm of the external aspect of the lip (lipstick area), subungual skin (area beneath the nail plate of a finger or toe), external auditory canal skin (in the ear), and anogenital skin 
Conditions not covered by SOP
  • Carcinoid tumour #
  • Hodgkin lymphoma *
  • Kaposi’s sarcoma of the skin *
  • Keratoacanthoma #
  • Lymphoma of the skin* - Hodgkin's lymphoma or non-Hodgkin's lymphoma
  • Malignant melanoma of the skin*
  • Mammary and extramammary Paget disease * Malignant neoplasm of the breast or non-SoP
  • Merkel cell carcinoma *
  • Non-melanoma malignant neoplasm mucosa lining the oral (inner aspects of the lips, conjunctiva and anogenital mucosa) #
  • Non-Hodgkin lymphoma *
  • Soft tissue sarcoma* of the skin
  • Solar keratosis*

* another SOP applies  - the SOP has the same name unless otherwise specified

# non-SOP condition

Clinical onset

The clinical onset is defined as the first appearance of clinical signs consistent with a non-melanoma malignant neoplasm, as documented by the treating doctor, and subsequently confirmed by histopathology examination. 

Clinical worsening

For clinical worsening, the SOP only has an 'inability to obtain appropriate clinical management factor.'  Failure to undergo timely treatment could result in permanent worsening in the form or local invasion/destruction of normal tissue, metastasis or death from the disease.

 

Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/n-p/non-melanotic-malignant-neoplasm-skin-b046-c000c001c002c00/rulebase-non-melanotic-malignant-neoplasm-skin/exposure-arsenic

Last amended

Having been a prisoner of war of the Japanese

Current RMA Instruments:
 
Reasonable Hypothesis SOP
78 of 2024
Balance of Probabilities SOP
79 of 2024
Changes from previous Instruments:

 

ICD Coding:
  • ICD-10-AM Codes: C00.0, C00.1, C00.2, C00.6, C00.8, C00.9, C44, C51.0, C51.1, C51.2, C51.8, C51.9, C60.0, C60.1, C60.2, C60.8, C60.9, C63.2, D04, D07.1, D07.4
Brief description:

Non melanoma malignant neoplasms are cancers that arise from skin cells other than melanocytes. The two main types are basal and squamous cell carcinoma of the skin. Basal cell carcinomas are the most common and make up approximately 70% of non-melanoma skin cancers. 

 

Confirming the diagnosis:

To confirm the diagnosis, there needs to be a histopathology report confirming a non-melanoma malignant neoplasm (with the specific diagnosis). 

To establish this diagnosis, the assessment and/or management may involve consultation with the following medical specialists: a dermatologist, a plastic surgeon and/or an oncologist. 

Diagnoses covered by SOP
  • Basal cell carcinoma (BCC) of the skin 
  • Bowen’s disease
  • Carcinoma-in-situ of the skin
  • Squamous cell carcinoma (SCC) of the skin
  • BCC or SCC of anogenital skin (including skin of penis)
  • Non-melanoma malignant neoplasm of the external aspect of the lip (lipstick area), subungual skin (area beneath the nail plate of a finger or toe), external auditory canal skin (in the ear), and anogenital skin 
Conditions not covered by SOP
  • Carcinoid tumour #
  • Hodgkin lymphoma *
  • Kaposi’s sarcoma of the skin *
  • Keratoacanthoma #
  • Lymphoma of the skin* - Hodgkin's lymphoma or non-Hodgkin's lymphoma
  • Malignant melanoma of the skin*
  • Mammary and extramammary Paget disease * Malignant neoplasm of the breast or non-SoP
  • Merkel cell carcinoma *
  • Non-melanoma malignant neoplasm mucosa lining the oral (inner aspects of the lips, conjunctiva and anogenital mucosa) #
  • Non-Hodgkin lymphoma *
  • Soft tissue sarcoma* of the skin
  • Solar keratosis*

* another SOP applies  - the SOP has the same name unless otherwise specified

# non-SOP condition

Clinical onset

The clinical onset is defined as the first appearance of clinical signs consistent with a non-melanoma malignant neoplasm, as documented by the treating doctor, and subsequently confirmed by histopathology examination. 

Clinical worsening

For clinical worsening, the SOP only has an 'inability to obtain appropriate clinical management factor.'  Failure to undergo timely treatment could result in permanent worsening in the form or local invasion/destruction of normal tissue, metastasis or death from the disease.

 

Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/n-p/non-melanotic-malignant-neoplasm-skin-b046-c000c001c002c00/rulebase-non-melanotic-malignant-neoplasm-skin/having-been-prisoner-war-japanese

Last amended

Human papilloma virus infection

Current RMA Instruments:
 
Reasonable Hypothesis SOP
78 of 2024
Balance of Probabilities SOP
79 of 2024
Changes from previous Instruments:

 

ICD Coding:
  • ICD-10-AM Codes: C00.0, C00.1, C00.2, C00.6, C00.8, C00.9, C44, C51.0, C51.1, C51.2, C51.8, C51.9, C60.0, C60.1, C60.2, C60.8, C60.9, C63.2, D04, D07.1, D07.4
Brief description:

Non melanoma malignant neoplasms are cancers that arise from skin cells other than melanocytes. The two main types are basal and squamous cell carcinoma of the skin. Basal cell carcinomas are the most common and make up approximately 70% of non-melanoma skin cancers. 

 

Confirming the diagnosis:

To confirm the diagnosis, there needs to be a histopathology report confirming a non-melanoma malignant neoplasm (with the specific diagnosis). 

To establish this diagnosis, the assessment and/or management may involve consultation with the following medical specialists: a dermatologist, a plastic surgeon and/or an oncologist. 

Diagnoses covered by SOP
  • Basal cell carcinoma (BCC) of the skin 
  • Bowen’s disease
  • Carcinoma-in-situ of the skin
  • Squamous cell carcinoma (SCC) of the skin
  • BCC or SCC of anogenital skin (including skin of penis)
  • Non-melanoma malignant neoplasm of the external aspect of the lip (lipstick area), subungual skin (area beneath the nail plate of a finger or toe), external auditory canal skin (in the ear), and anogenital skin 
Conditions not covered by SOP
  • Carcinoid tumour #
  • Hodgkin lymphoma *
  • Kaposi’s sarcoma of the skin *
  • Keratoacanthoma #
  • Lymphoma of the skin* - Hodgkin's lymphoma or non-Hodgkin's lymphoma
  • Malignant melanoma of the skin*
  • Mammary and extramammary Paget disease * Malignant neoplasm of the breast or non-SoP
  • Merkel cell carcinoma *
  • Non-melanoma malignant neoplasm mucosa lining the oral (inner aspects of the lips, conjunctiva and anogenital mucosa) #
  • Non-Hodgkin lymphoma *
  • Soft tissue sarcoma* of the skin
  • Solar keratosis*

* another SOP applies  - the SOP has the same name unless otherwise specified

# non-SOP condition

Clinical onset

The clinical onset is defined as the first appearance of clinical signs consistent with a non-melanoma malignant neoplasm, as documented by the treating doctor, and subsequently confirmed by histopathology examination. 

Clinical worsening

For clinical worsening, the SOP only has an 'inability to obtain appropriate clinical management factor.'  Failure to undergo timely treatment could result in permanent worsening in the form or local invasion/destruction of normal tissue, metastasis or death from the disease.

 

Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/n-p/non-melanotic-malignant-neoplasm-skin-b046-c000c001c002c00/rulebase-non-melanotic-malignant-neoplasm-skin/human-papilloma-virus-infection

Last amended

Immunosuppressive drugs

Current RMA Instruments:
 
Reasonable Hypothesis SOP
78 of 2024
Balance of Probabilities SOP
79 of 2024
Changes from previous Instruments:

 

ICD Coding:
  • ICD-10-AM Codes: C00.0, C00.1, C00.2, C00.6, C00.8, C00.9, C44, C51.0, C51.1, C51.2, C51.8, C51.9, C60.0, C60.1, C60.2, C60.8, C60.9, C63.2, D04, D07.1, D07.4
Brief description:

Non melanoma malignant neoplasms are cancers that arise from skin cells other than melanocytes. The two main types are basal and squamous cell carcinoma of the skin. Basal cell carcinomas are the most common and make up approximately 70% of non-melanoma skin cancers. 

 

Confirming the diagnosis:

To confirm the diagnosis, there needs to be a histopathology report confirming a non-melanoma malignant neoplasm (with the specific diagnosis). 

To establish this diagnosis, the assessment and/or management may involve consultation with the following medical specialists: a dermatologist, a plastic surgeon and/or an oncologist. 

Diagnoses covered by SOP
  • Basal cell carcinoma (BCC) of the skin 
  • Bowen’s disease
  • Carcinoma-in-situ of the skin
  • Squamous cell carcinoma (SCC) of the skin
  • BCC or SCC of anogenital skin (including skin of penis)
  • Non-melanoma malignant neoplasm of the external aspect of the lip (lipstick area), subungual skin (area beneath the nail plate of a finger or toe), external auditory canal skin (in the ear), and anogenital skin 
Conditions not covered by SOP
  • Carcinoid tumour #
  • Hodgkin lymphoma *
  • Kaposi’s sarcoma of the skin *
  • Keratoacanthoma #
  • Lymphoma of the skin* - Hodgkin's lymphoma or non-Hodgkin's lymphoma
  • Malignant melanoma of the skin*
  • Mammary and extramammary Paget disease * Malignant neoplasm of the breast or non-SoP
  • Merkel cell carcinoma *
  • Non-melanoma malignant neoplasm mucosa lining the oral (inner aspects of the lips, conjunctiva and anogenital mucosa) #
  • Non-Hodgkin lymphoma *
  • Soft tissue sarcoma* of the skin
  • Solar keratosis*

* another SOP applies  - the SOP has the same name unless otherwise specified

# non-SOP condition

Clinical onset

The clinical onset is defined as the first appearance of clinical signs consistent with a non-melanoma malignant neoplasm, as documented by the treating doctor, and subsequently confirmed by histopathology examination. 

Clinical worsening

For clinical worsening, the SOP only has an 'inability to obtain appropriate clinical management factor.'  Failure to undergo timely treatment could result in permanent worsening in the form or local invasion/destruction of normal tissue, metastasis or death from the disease.

 

Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/n-p/non-melanotic-malignant-neoplasm-skin-b046-c000c001c002c00/rulebase-non-melanotic-malignant-neoplasm-skin/immunosuppressive-drugs

Last amended

Increased risk due to solar exposure on service

Current RMA Instruments:
 
Reasonable Hypothesis SOP
78 of 2024
Balance of Probabilities SOP
79 of 2024
Changes from previous Instruments:

 

ICD Coding:
  • ICD-10-AM Codes: C00.0, C00.1, C00.2, C00.6, C00.8, C00.9, C44, C51.0, C51.1, C51.2, C51.8, C51.9, C60.0, C60.1, C60.2, C60.8, C60.9, C63.2, D04, D07.1, D07.4
Brief description:

Non melanoma malignant neoplasms are cancers that arise from skin cells other than melanocytes. The two main types are basal and squamous cell carcinoma of the skin. Basal cell carcinomas are the most common and make up approximately 70% of non-melanoma skin cancers. 

 

Confirming the diagnosis:

To confirm the diagnosis, there needs to be a histopathology report confirming a non-melanoma malignant neoplasm (with the specific diagnosis). 

To establish this diagnosis, the assessment and/or management may involve consultation with the following medical specialists: a dermatologist, a plastic surgeon and/or an oncologist. 

Diagnoses covered by SOP
  • Basal cell carcinoma (BCC) of the skin 
  • Bowen’s disease
  • Carcinoma-in-situ of the skin
  • Squamous cell carcinoma (SCC) of the skin
  • BCC or SCC of anogenital skin (including skin of penis)
  • Non-melanoma malignant neoplasm of the external aspect of the lip (lipstick area), subungual skin (area beneath the nail plate of a finger or toe), external auditory canal skin (in the ear), and anogenital skin 
Conditions not covered by SOP
  • Carcinoid tumour #
  • Hodgkin lymphoma *
  • Kaposi’s sarcoma of the skin *
  • Keratoacanthoma #
  • Lymphoma of the skin* - Hodgkin's lymphoma or non-Hodgkin's lymphoma
  • Malignant melanoma of the skin*
  • Mammary and extramammary Paget disease * Malignant neoplasm of the breast or non-SoP
  • Merkel cell carcinoma *
  • Non-melanoma malignant neoplasm mucosa lining the oral (inner aspects of the lips, conjunctiva and anogenital mucosa) #
  • Non-Hodgkin lymphoma *
  • Soft tissue sarcoma* of the skin
  • Solar keratosis*

* another SOP applies  - the SOP has the same name unless otherwise specified

# non-SOP condition

Clinical onset

The clinical onset is defined as the first appearance of clinical signs consistent with a non-melanoma malignant neoplasm, as documented by the treating doctor, and subsequently confirmed by histopathology examination. 

Clinical worsening

For clinical worsening, the SOP only has an 'inability to obtain appropriate clinical management factor.'  Failure to undergo timely treatment could result in permanent worsening in the form or local invasion/destruction of normal tissue, metastasis or death from the disease.

 

Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/n-p/non-melanotic-malignant-neoplasm-skin-b046-c000c001c002c00/rulebase-non-melanotic-malignant-neoplasm-skin/increased-risk-due-solar-exposure-service

Last amended

Infected cutaneous sinus tract

Current RMA Instruments:
 
Reasonable Hypothesis SOP
78 of 2024
Balance of Probabilities SOP
79 of 2024
Changes from previous Instruments:

 

ICD Coding:
  • ICD-10-AM Codes: C00.0, C00.1, C00.2, C00.6, C00.8, C00.9, C44, C51.0, C51.1, C51.2, C51.8, C51.9, C60.0, C60.1, C60.2, C60.8, C60.9, C63.2, D04, D07.1, D07.4
Brief description:

Non melanoma malignant neoplasms are cancers that arise from skin cells other than melanocytes. The two main types are basal and squamous cell carcinoma of the skin. Basal cell carcinomas are the most common and make up approximately 70% of non-melanoma skin cancers. 

 

Confirming the diagnosis:

To confirm the diagnosis, there needs to be a histopathology report confirming a non-melanoma malignant neoplasm (with the specific diagnosis). 

To establish this diagnosis, the assessment and/or management may involve consultation with the following medical specialists: a dermatologist, a plastic surgeon and/or an oncologist. 

Diagnoses covered by SOP
  • Basal cell carcinoma (BCC) of the skin 
  • Bowen’s disease
  • Carcinoma-in-situ of the skin
  • Squamous cell carcinoma (SCC) of the skin
  • BCC or SCC of anogenital skin (including skin of penis)
  • Non-melanoma malignant neoplasm of the external aspect of the lip (lipstick area), subungual skin (area beneath the nail plate of a finger or toe), external auditory canal skin (in the ear), and anogenital skin 
Conditions not covered by SOP
  • Carcinoid tumour #
  • Hodgkin lymphoma *
  • Kaposi’s sarcoma of the skin *
  • Keratoacanthoma #
  • Lymphoma of the skin* - Hodgkin's lymphoma or non-Hodgkin's lymphoma
  • Malignant melanoma of the skin*
  • Mammary and extramammary Paget disease * Malignant neoplasm of the breast or non-SoP
  • Merkel cell carcinoma *
  • Non-melanoma malignant neoplasm mucosa lining the oral (inner aspects of the lips, conjunctiva and anogenital mucosa) #
  • Non-Hodgkin lymphoma *
  • Soft tissue sarcoma* of the skin
  • Solar keratosis*

* another SOP applies  - the SOP has the same name unless otherwise specified

# non-SOP condition

Clinical onset

The clinical onset is defined as the first appearance of clinical signs consistent with a non-melanoma malignant neoplasm, as documented by the treating doctor, and subsequently confirmed by histopathology examination. 

Clinical worsening

For clinical worsening, the SOP only has an 'inability to obtain appropriate clinical management factor.'  Failure to undergo timely treatment could result in permanent worsening in the form or local invasion/destruction of normal tissue, metastasis or death from the disease.

 

Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/n-p/non-melanotic-malignant-neoplasm-skin-b046-c000c001c002c00/rulebase-non-melanotic-malignant-neoplasm-skin/infected-cutaneous-sinus-tract

Last amended

Infection with the human immunodeficiency virus (HIV)

Current RMA Instruments:
 
Reasonable Hypothesis SOP
78 of 2024
Balance of Probabilities SOP
79 of 2024
Changes from previous Instruments:

 

ICD Coding:
  • ICD-10-AM Codes: C00.0, C00.1, C00.2, C00.6, C00.8, C00.9, C44, C51.0, C51.1, C51.2, C51.8, C51.9, C60.0, C60.1, C60.2, C60.8, C60.9, C63.2, D04, D07.1, D07.4
Brief description:

Non melanoma malignant neoplasms are cancers that arise from skin cells other than melanocytes. The two main types are basal and squamous cell carcinoma of the skin. Basal cell carcinomas are the most common and make up approximately 70% of non-melanoma skin cancers. 

 

Confirming the diagnosis:

To confirm the diagnosis, there needs to be a histopathology report confirming a non-melanoma malignant neoplasm (with the specific diagnosis). 

To establish this diagnosis, the assessment and/or management may involve consultation with the following medical specialists: a dermatologist, a plastic surgeon and/or an oncologist. 

Diagnoses covered by SOP
  • Basal cell carcinoma (BCC) of the skin 
  • Bowen’s disease
  • Carcinoma-in-situ of the skin
  • Squamous cell carcinoma (SCC) of the skin
  • BCC or SCC of anogenital skin (including skin of penis)
  • Non-melanoma malignant neoplasm of the external aspect of the lip (lipstick area), subungual skin (area beneath the nail plate of a finger or toe), external auditory canal skin (in the ear), and anogenital skin 
Conditions not covered by SOP
  • Carcinoid tumour #
  • Hodgkin lymphoma *
  • Kaposi’s sarcoma of the skin *
  • Keratoacanthoma #
  • Lymphoma of the skin* - Hodgkin's lymphoma or non-Hodgkin's lymphoma
  • Malignant melanoma of the skin*
  • Mammary and extramammary Paget disease * Malignant neoplasm of the breast or non-SoP
  • Merkel cell carcinoma *
  • Non-melanoma malignant neoplasm mucosa lining the oral (inner aspects of the lips, conjunctiva and anogenital mucosa) #
  • Non-Hodgkin lymphoma *
  • Soft tissue sarcoma* of the skin
  • Solar keratosis*

* another SOP applies  - the SOP has the same name unless otherwise specified

# non-SOP condition

Clinical onset

The clinical onset is defined as the first appearance of clinical signs consistent with a non-melanoma malignant neoplasm, as documented by the treating doctor, and subsequently confirmed by histopathology examination. 

Clinical worsening

For clinical worsening, the SOP only has an 'inability to obtain appropriate clinical management factor.'  Failure to undergo timely treatment could result in permanent worsening in the form or local invasion/destruction of normal tissue, metastasis or death from the disease.

 

Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/n-p/non-melanotic-malignant-neoplasm-skin-b046-c000c001c002c00/rulebase-non-melanotic-malignant-neoplasm-skin/infection-human-immunodeficiency-virus-hiv

Last amended

Lichen sclerosis

Current RMA Instruments:
 
Reasonable Hypothesis SOP
78 of 2024
Balance of Probabilities SOP
79 of 2024
Changes from previous Instruments:

 

ICD Coding:
  • ICD-10-AM Codes: C00.0, C00.1, C00.2, C00.6, C00.8, C00.9, C44, C51.0, C51.1, C51.2, C51.8, C51.9, C60.0, C60.1, C60.2, C60.8, C60.9, C63.2, D04, D07.1, D07.4
Brief description:

Non melanoma malignant neoplasms are cancers that arise from skin cells other than melanocytes. The two main types are basal and squamous cell carcinoma of the skin. Basal cell carcinomas are the most common and make up approximately 70% of non-melanoma skin cancers. 

 

Confirming the diagnosis:

To confirm the diagnosis, there needs to be a histopathology report confirming a non-melanoma malignant neoplasm (with the specific diagnosis). 

To establish this diagnosis, the assessment and/or management may involve consultation with the following medical specialists: a dermatologist, a plastic surgeon and/or an oncologist. 

Diagnoses covered by SOP
  • Basal cell carcinoma (BCC) of the skin 
  • Bowen’s disease
  • Carcinoma-in-situ of the skin
  • Squamous cell carcinoma (SCC) of the skin
  • BCC or SCC of anogenital skin (including skin of penis)
  • Non-melanoma malignant neoplasm of the external aspect of the lip (lipstick area), subungual skin (area beneath the nail plate of a finger or toe), external auditory canal skin (in the ear), and anogenital skin 
Conditions not covered by SOP
  • Carcinoid tumour #
  • Hodgkin lymphoma *
  • Kaposi’s sarcoma of the skin *
  • Keratoacanthoma #
  • Lymphoma of the skin* - Hodgkin's lymphoma or non-Hodgkin's lymphoma
  • Malignant melanoma of the skin*
  • Mammary and extramammary Paget disease * Malignant neoplasm of the breast or non-SoP
  • Merkel cell carcinoma *
  • Non-melanoma malignant neoplasm mucosa lining the oral (inner aspects of the lips, conjunctiva and anogenital mucosa) #
  • Non-Hodgkin lymphoma *
  • Soft tissue sarcoma* of the skin
  • Solar keratosis*

* another SOP applies  - the SOP has the same name unless otherwise specified

# non-SOP condition

Clinical onset

The clinical onset is defined as the first appearance of clinical signs consistent with a non-melanoma malignant neoplasm, as documented by the treating doctor, and subsequently confirmed by histopathology examination. 

Clinical worsening

For clinical worsening, the SOP only has an 'inability to obtain appropriate clinical management factor.'  Failure to undergo timely treatment could result in permanent worsening in the form or local invasion/destruction of normal tissue, metastasis or death from the disease.

 

Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/n-p/non-melanotic-malignant-neoplasm-skin-b046-c000c001c002c00/rulebase-non-melanotic-malignant-neoplasm-skin/lichen-sclerosis

Last amended

No clinical management for non melanotic malignant neoplasm of the skin

Current RMA Instruments:
 
Reasonable Hypothesis SOP
78 of 2024
Balance of Probabilities SOP
79 of 2024
Changes from previous Instruments:

 

ICD Coding:
  • ICD-10-AM Codes: C00.0, C00.1, C00.2, C00.6, C00.8, C00.9, C44, C51.0, C51.1, C51.2, C51.8, C51.9, C60.0, C60.1, C60.2, C60.8, C60.9, C63.2, D04, D07.1, D07.4
Brief description:

Non melanoma malignant neoplasms are cancers that arise from skin cells other than melanocytes. The two main types are basal and squamous cell carcinoma of the skin. Basal cell carcinomas are the most common and make up approximately 70% of non-melanoma skin cancers. 

 

Confirming the diagnosis:

To confirm the diagnosis, there needs to be a histopathology report confirming a non-melanoma malignant neoplasm (with the specific diagnosis). 

To establish this diagnosis, the assessment and/or management may involve consultation with the following medical specialists: a dermatologist, a plastic surgeon and/or an oncologist. 

Diagnoses covered by SOP
  • Basal cell carcinoma (BCC) of the skin 
  • Bowen’s disease
  • Carcinoma-in-situ of the skin
  • Squamous cell carcinoma (SCC) of the skin
  • BCC or SCC of anogenital skin (including skin of penis)
  • Non-melanoma malignant neoplasm of the external aspect of the lip (lipstick area), subungual skin (area beneath the nail plate of a finger or toe), external auditory canal skin (in the ear), and anogenital skin 
Conditions not covered by SOP
  • Carcinoid tumour #
  • Hodgkin lymphoma *
  • Kaposi’s sarcoma of the skin *
  • Keratoacanthoma #
  • Lymphoma of the skin* - Hodgkin's lymphoma or non-Hodgkin's lymphoma
  • Malignant melanoma of the skin*
  • Mammary and extramammary Paget disease * Malignant neoplasm of the breast or non-SoP
  • Merkel cell carcinoma *
  • Non-melanoma malignant neoplasm mucosa lining the oral (inner aspects of the lips, conjunctiva and anogenital mucosa) #
  • Non-Hodgkin lymphoma *
  • Soft tissue sarcoma* of the skin
  • Solar keratosis*

* another SOP applies  - the SOP has the same name unless otherwise specified

# non-SOP condition

Clinical onset

The clinical onset is defined as the first appearance of clinical signs consistent with a non-melanoma malignant neoplasm, as documented by the treating doctor, and subsequently confirmed by histopathology examination. 

Clinical worsening

For clinical worsening, the SOP only has an 'inability to obtain appropriate clinical management factor.'  Failure to undergo timely treatment could result in permanent worsening in the form or local invasion/destruction of normal tissue, metastasis or death from the disease.

 

Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/n-p/non-melanotic-malignant-neoplasm-skin-b046-c000c001c002c00/rulebase-non-melanotic-malignant-neoplasm-skin/no-clinical-management-non-melanotic-malignant-neoplasm-skin

Last amended

Non-Hodgkin's lymphoma or chronic lymphoid leukaemia

Current RMA Instruments:
 
Reasonable Hypothesis SOP
78 of 2024
Balance of Probabilities SOP
79 of 2024
Changes from previous Instruments:

 

ICD Coding:
  • ICD-10-AM Codes: C00.0, C00.1, C00.2, C00.6, C00.8, C00.9, C44, C51.0, C51.1, C51.2, C51.8, C51.9, C60.0, C60.1, C60.2, C60.8, C60.9, C63.2, D04, D07.1, D07.4
Brief description:

Non melanoma malignant neoplasms are cancers that arise from skin cells other than melanocytes. The two main types are basal and squamous cell carcinoma of the skin. Basal cell carcinomas are the most common and make up approximately 70% of non-melanoma skin cancers. 

 

Confirming the diagnosis:

To confirm the diagnosis, there needs to be a histopathology report confirming a non-melanoma malignant neoplasm (with the specific diagnosis). 

To establish this diagnosis, the assessment and/or management may involve consultation with the following medical specialists: a dermatologist, a plastic surgeon and/or an oncologist. 

Diagnoses covered by SOP
  • Basal cell carcinoma (BCC) of the skin 
  • Bowen’s disease
  • Carcinoma-in-situ of the skin
  • Squamous cell carcinoma (SCC) of the skin
  • BCC or SCC of anogenital skin (including skin of penis)
  • Non-melanoma malignant neoplasm of the external aspect of the lip (lipstick area), subungual skin (area beneath the nail plate of a finger or toe), external auditory canal skin (in the ear), and anogenital skin 
Conditions not covered by SOP
  • Carcinoid tumour #
  • Hodgkin lymphoma *
  • Kaposi’s sarcoma of the skin *
  • Keratoacanthoma #
  • Lymphoma of the skin* - Hodgkin's lymphoma or non-Hodgkin's lymphoma
  • Malignant melanoma of the skin*
  • Mammary and extramammary Paget disease * Malignant neoplasm of the breast or non-SoP
  • Merkel cell carcinoma *
  • Non-melanoma malignant neoplasm mucosa lining the oral (inner aspects of the lips, conjunctiva and anogenital mucosa) #
  • Non-Hodgkin lymphoma *
  • Soft tissue sarcoma* of the skin
  • Solar keratosis*

* another SOP applies  - the SOP has the same name unless otherwise specified

# non-SOP condition

Clinical onset

The clinical onset is defined as the first appearance of clinical signs consistent with a non-melanoma malignant neoplasm, as documented by the treating doctor, and subsequently confirmed by histopathology examination. 

Clinical worsening

For clinical worsening, the SOP only has an 'inability to obtain appropriate clinical management factor.'  Failure to undergo timely treatment could result in permanent worsening in the form or local invasion/destruction of normal tissue, metastasis or death from the disease.

 

Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/n-p/non-melanotic-malignant-neoplasm-skin-b046-c000c001c002c00/rulebase-non-melanotic-malignant-neoplasm-skin/non-hodgkins-lymphoma-or-chronic-lymphoid-leukaemia

Last amended

Phimosis

Current RMA Instruments:
 
Reasonable Hypothesis SOP
78 of 2024
Balance of Probabilities SOP
79 of 2024
Changes from previous Instruments:

 

ICD Coding:
  • ICD-10-AM Codes: C00.0, C00.1, C00.2, C00.6, C00.8, C00.9, C44, C51.0, C51.1, C51.2, C51.8, C51.9, C60.0, C60.1, C60.2, C60.8, C60.9, C63.2, D04, D07.1, D07.4
Brief description:

Non melanoma malignant neoplasms are cancers that arise from skin cells other than melanocytes. The two main types are basal and squamous cell carcinoma of the skin. Basal cell carcinomas are the most common and make up approximately 70% of non-melanoma skin cancers. 

 

Confirming the diagnosis:

To confirm the diagnosis, there needs to be a histopathology report confirming a non-melanoma malignant neoplasm (with the specific diagnosis). 

To establish this diagnosis, the assessment and/or management may involve consultation with the following medical specialists: a dermatologist, a plastic surgeon and/or an oncologist. 

Diagnoses covered by SOP
  • Basal cell carcinoma (BCC) of the skin 
  • Bowen’s disease
  • Carcinoma-in-situ of the skin
  • Squamous cell carcinoma (SCC) of the skin
  • BCC or SCC of anogenital skin (including skin of penis)
  • Non-melanoma malignant neoplasm of the external aspect of the lip (lipstick area), subungual skin (area beneath the nail plate of a finger or toe), external auditory canal skin (in the ear), and anogenital skin 
Conditions not covered by SOP
  • Carcinoid tumour #
  • Hodgkin lymphoma *
  • Kaposi’s sarcoma of the skin *
  • Keratoacanthoma #
  • Lymphoma of the skin* - Hodgkin's lymphoma or non-Hodgkin's lymphoma
  • Malignant melanoma of the skin*
  • Mammary and extramammary Paget disease * Malignant neoplasm of the breast or non-SoP
  • Merkel cell carcinoma *
  • Non-melanoma malignant neoplasm mucosa lining the oral (inner aspects of the lips, conjunctiva and anogenital mucosa) #
  • Non-Hodgkin lymphoma *
  • Soft tissue sarcoma* of the skin
  • Solar keratosis*

* another SOP applies  - the SOP has the same name unless otherwise specified

# non-SOP condition

Clinical onset

The clinical onset is defined as the first appearance of clinical signs consistent with a non-melanoma malignant neoplasm, as documented by the treating doctor, and subsequently confirmed by histopathology examination. 

Clinical worsening

For clinical worsening, the SOP only has an 'inability to obtain appropriate clinical management factor.'  Failure to undergo timely treatment could result in permanent worsening in the form or local invasion/destruction of normal tissue, metastasis or death from the disease.

 

Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/n-p/non-melanotic-malignant-neoplasm-skin-b046-c000c001c002c00/rulebase-non-melanotic-malignant-neoplasm-skin/phimosis

Last amended

Pipe smoking

Current RMA Instruments:
 
Reasonable Hypothesis SOP
78 of 2024
Balance of Probabilities SOP
79 of 2024
Changes from previous Instruments:

 

ICD Coding:
  • ICD-10-AM Codes: C00.0, C00.1, C00.2, C00.6, C00.8, C00.9, C44, C51.0, C51.1, C51.2, C51.8, C51.9, C60.0, C60.1, C60.2, C60.8, C60.9, C63.2, D04, D07.1, D07.4
Brief description:

Non melanoma malignant neoplasms are cancers that arise from skin cells other than melanocytes. The two main types are basal and squamous cell carcinoma of the skin. Basal cell carcinomas are the most common and make up approximately 70% of non-melanoma skin cancers. 

 

Confirming the diagnosis:

To confirm the diagnosis, there needs to be a histopathology report confirming a non-melanoma malignant neoplasm (with the specific diagnosis). 

To establish this diagnosis, the assessment and/or management may involve consultation with the following medical specialists: a dermatologist, a plastic surgeon and/or an oncologist. 

Diagnoses covered by SOP
  • Basal cell carcinoma (BCC) of the skin 
  • Bowen’s disease
  • Carcinoma-in-situ of the skin
  • Squamous cell carcinoma (SCC) of the skin
  • BCC or SCC of anogenital skin (including skin of penis)
  • Non-melanoma malignant neoplasm of the external aspect of the lip (lipstick area), subungual skin (area beneath the nail plate of a finger or toe), external auditory canal skin (in the ear), and anogenital skin 
Conditions not covered by SOP
  • Carcinoid tumour #
  • Hodgkin lymphoma *
  • Kaposi’s sarcoma of the skin *
  • Keratoacanthoma #
  • Lymphoma of the skin* - Hodgkin's lymphoma or non-Hodgkin's lymphoma
  • Malignant melanoma of the skin*
  • Mammary and extramammary Paget disease * Malignant neoplasm of the breast or non-SoP
  • Merkel cell carcinoma *
  • Non-melanoma malignant neoplasm mucosa lining the oral (inner aspects of the lips, conjunctiva and anogenital mucosa) #
  • Non-Hodgkin lymphoma *
  • Soft tissue sarcoma* of the skin
  • Solar keratosis*

* another SOP applies  - the SOP has the same name unless otherwise specified

# non-SOP condition

Clinical onset

The clinical onset is defined as the first appearance of clinical signs consistent with a non-melanoma malignant neoplasm, as documented by the treating doctor, and subsequently confirmed by histopathology examination. 

Clinical worsening

For clinical worsening, the SOP only has an 'inability to obtain appropriate clinical management factor.'  Failure to undergo timely treatment could result in permanent worsening in the form or local invasion/destruction of normal tissue, metastasis or death from the disease.

 

Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/n-p/non-melanotic-malignant-neoplasm-skin-b046-c000c001c002c00/rulebase-non-melanotic-malignant-neoplasm-skin/pipe-smoking

Last amended

Prolonged sunlight exposure

Current RMA Instruments:
 
Reasonable Hypothesis SOP
78 of 2024
Balance of Probabilities SOP
79 of 2024
Changes from previous Instruments:

 

ICD Coding:
  • ICD-10-AM Codes: C00.0, C00.1, C00.2, C00.6, C00.8, C00.9, C44, C51.0, C51.1, C51.2, C51.8, C51.9, C60.0, C60.1, C60.2, C60.8, C60.9, C63.2, D04, D07.1, D07.4
Brief description:

Non melanoma malignant neoplasms are cancers that arise from skin cells other than melanocytes. The two main types are basal and squamous cell carcinoma of the skin. Basal cell carcinomas are the most common and make up approximately 70% of non-melanoma skin cancers. 

 

Confirming the diagnosis:

To confirm the diagnosis, there needs to be a histopathology report confirming a non-melanoma malignant neoplasm (with the specific diagnosis). 

To establish this diagnosis, the assessment and/or management may involve consultation with the following medical specialists: a dermatologist, a plastic surgeon and/or an oncologist. 

Diagnoses covered by SOP
  • Basal cell carcinoma (BCC) of the skin 
  • Bowen’s disease
  • Carcinoma-in-situ of the skin
  • Squamous cell carcinoma (SCC) of the skin
  • BCC or SCC of anogenital skin (including skin of penis)
  • Non-melanoma malignant neoplasm of the external aspect of the lip (lipstick area), subungual skin (area beneath the nail plate of a finger or toe), external auditory canal skin (in the ear), and anogenital skin 
Conditions not covered by SOP
  • Carcinoid tumour #
  • Hodgkin lymphoma *
  • Kaposi’s sarcoma of the skin *
  • Keratoacanthoma #
  • Lymphoma of the skin* - Hodgkin's lymphoma or non-Hodgkin's lymphoma
  • Malignant melanoma of the skin*
  • Mammary and extramammary Paget disease * Malignant neoplasm of the breast or non-SoP
  • Merkel cell carcinoma *
  • Non-melanoma malignant neoplasm mucosa lining the oral (inner aspects of the lips, conjunctiva and anogenital mucosa) #
  • Non-Hodgkin lymphoma *
  • Soft tissue sarcoma* of the skin
  • Solar keratosis*

* another SOP applies  - the SOP has the same name unless otherwise specified

# non-SOP condition

Clinical onset

The clinical onset is defined as the first appearance of clinical signs consistent with a non-melanoma malignant neoplasm, as documented by the treating doctor, and subsequently confirmed by histopathology examination. 

Clinical worsening

For clinical worsening, the SOP only has an 'inability to obtain appropriate clinical management factor.'  Failure to undergo timely treatment could result in permanent worsening in the form or local invasion/destruction of normal tissue, metastasis or death from the disease.

 

Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/n-p/non-melanotic-malignant-neoplasm-skin-b046-c000c001c002c00/rulebase-non-melanotic-malignant-neoplasm-skin/prolonged-sunlight-exposure

Last amended

PUVA treatment

Current RMA Instruments:
 
Reasonable Hypothesis SOP
78 of 2024
Balance of Probabilities SOP
79 of 2024
Changes from previous Instruments:

 

ICD Coding:
  • ICD-10-AM Codes: C00.0, C00.1, C00.2, C00.6, C00.8, C00.9, C44, C51.0, C51.1, C51.2, C51.8, C51.9, C60.0, C60.1, C60.2, C60.8, C60.9, C63.2, D04, D07.1, D07.4
Brief description:

Non melanoma malignant neoplasms are cancers that arise from skin cells other than melanocytes. The two main types are basal and squamous cell carcinoma of the skin. Basal cell carcinomas are the most common and make up approximately 70% of non-melanoma skin cancers. 

 

Confirming the diagnosis:

To confirm the diagnosis, there needs to be a histopathology report confirming a non-melanoma malignant neoplasm (with the specific diagnosis). 

To establish this diagnosis, the assessment and/or management may involve consultation with the following medical specialists: a dermatologist, a plastic surgeon and/or an oncologist. 

Diagnoses covered by SOP
  • Basal cell carcinoma (BCC) of the skin 
  • Bowen’s disease
  • Carcinoma-in-situ of the skin
  • Squamous cell carcinoma (SCC) of the skin
  • BCC or SCC of anogenital skin (including skin of penis)
  • Non-melanoma malignant neoplasm of the external aspect of the lip (lipstick area), subungual skin (area beneath the nail plate of a finger or toe), external auditory canal skin (in the ear), and anogenital skin 
Conditions not covered by SOP
  • Carcinoid tumour #
  • Hodgkin lymphoma *
  • Kaposi’s sarcoma of the skin *
  • Keratoacanthoma #
  • Lymphoma of the skin* - Hodgkin's lymphoma or non-Hodgkin's lymphoma
  • Malignant melanoma of the skin*
  • Mammary and extramammary Paget disease * Malignant neoplasm of the breast or non-SoP
  • Merkel cell carcinoma *
  • Non-melanoma malignant neoplasm mucosa lining the oral (inner aspects of the lips, conjunctiva and anogenital mucosa) #
  • Non-Hodgkin lymphoma *
  • Soft tissue sarcoma* of the skin
  • Solar keratosis*

* another SOP applies  - the SOP has the same name unless otherwise specified

# non-SOP condition

Clinical onset

The clinical onset is defined as the first appearance of clinical signs consistent with a non-melanoma malignant neoplasm, as documented by the treating doctor, and subsequently confirmed by histopathology examination. 

Clinical worsening

For clinical worsening, the SOP only has an 'inability to obtain appropriate clinical management factor.'  Failure to undergo timely treatment could result in permanent worsening in the form or local invasion/destruction of normal tissue, metastasis or death from the disease.

 

Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/n-p/non-melanotic-malignant-neoplasm-skin-b046-c000c001c002c00/rulebase-non-melanotic-malignant-neoplasm-skin/puva-treatment

Last amended

Smoking tobacco products - material contribution

Current RMA Instruments:
 
Reasonable Hypothesis SOP
78 of 2024
Balance of Probabilities SOP
79 of 2024
Changes from previous Instruments:

 

ICD Coding:
  • ICD-10-AM Codes: C00.0, C00.1, C00.2, C00.6, C00.8, C00.9, C44, C51.0, C51.1, C51.2, C51.8, C51.9, C60.0, C60.1, C60.2, C60.8, C60.9, C63.2, D04, D07.1, D07.4
Brief description:

Non melanoma malignant neoplasms are cancers that arise from skin cells other than melanocytes. The two main types are basal and squamous cell carcinoma of the skin. Basal cell carcinomas are the most common and make up approximately 70% of non-melanoma skin cancers. 

 

Confirming the diagnosis:

To confirm the diagnosis, there needs to be a histopathology report confirming a non-melanoma malignant neoplasm (with the specific diagnosis). 

To establish this diagnosis, the assessment and/or management may involve consultation with the following medical specialists: a dermatologist, a plastic surgeon and/or an oncologist. 

Diagnoses covered by SOP
  • Basal cell carcinoma (BCC) of the skin 
  • Bowen’s disease
  • Carcinoma-in-situ of the skin
  • Squamous cell carcinoma (SCC) of the skin
  • BCC or SCC of anogenital skin (including skin of penis)
  • Non-melanoma malignant neoplasm of the external aspect of the lip (lipstick area), subungual skin (area beneath the nail plate of a finger or toe), external auditory canal skin (in the ear), and anogenital skin 
Conditions not covered by SOP
  • Carcinoid tumour #
  • Hodgkin lymphoma *
  • Kaposi’s sarcoma of the skin *
  • Keratoacanthoma #
  • Lymphoma of the skin* - Hodgkin's lymphoma or non-Hodgkin's lymphoma
  • Malignant melanoma of the skin*
  • Mammary and extramammary Paget disease * Malignant neoplasm of the breast or non-SoP
  • Merkel cell carcinoma *
  • Non-melanoma malignant neoplasm mucosa lining the oral (inner aspects of the lips, conjunctiva and anogenital mucosa) #
  • Non-Hodgkin lymphoma *
  • Soft tissue sarcoma* of the skin
  • Solar keratosis*

* another SOP applies  - the SOP has the same name unless otherwise specified

# non-SOP condition

Clinical onset

The clinical onset is defined as the first appearance of clinical signs consistent with a non-melanoma malignant neoplasm, as documented by the treating doctor, and subsequently confirmed by histopathology examination. 

Clinical worsening

For clinical worsening, the SOP only has an 'inability to obtain appropriate clinical management factor.'  Failure to undergo timely treatment could result in permanent worsening in the form or local invasion/destruction of normal tissue, metastasis or death from the disease.

 

Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/n-p/non-melanotic-malignant-neoplasm-skin-b046-c000c001c002c00/rulebase-non-melanotic-malignant-neoplasm-skin/smoking-tobacco-products-material-contribution

Last amended